{
  "image_filename": "figure_p4_det_3_020.png",
  "image_path": "FlublokPI/extracted/figures/figure_p4_det_3_020.png",
  "image_type": "Figure",
  "page_number": 4,
  "block_id": "det_3_020",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "A table titled 'Adults 18\u201349 Years of Age, Study 1' showing number of cases and rates for Flublok (N=2344) versus saline placebo (N=2304) across different case definitions (CDC-ILI with matched strains, any ILI, positive culture with any strain, subtype A, type B), with columns for Flublok vaccine efficacy (%) and 95% confidence intervals. does not support the claim because the table compares Flublok only against saline placebo and makes no mention of Fluarix (quadrivalent standard-dose vaccine).",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "A table titled 'Adults 18\u201349 Years of Age, Study 1' showing number of cases and rates for Flublok (N=2344) versus saline placebo (N=2304) across different case definitions (CDC-ILI with matched strains, any ILI, positive culture with any strain, subtype A, type B), with columns for Flublok vaccine efficacy (%) and 95% confidence intervals.",
    "evidence_found": null,
    "reasoning": "does not support the claim because the table compares Flublok only against saline placebo and makes no mention of Fluarix (quadrivalent standard-dose vaccine).",
    "confidence_notes": null
  }
}